OHSU in the news

Oregon woman touts success of heart drug trial

KGW-TV June 13, 2023
OHSU patient Megan Link recently attended the World Heart Summit, where she shared her experience living with hypertrophic cardiomyopathy as well as her participation in a clinical trial evaluating an experimental drug for the heart condition. Ahmad Masri, M.D., says: “We’re very focused on … implementing the science and trying to get more options to patients.”

Teens seeking addiction care unlikely to be offered standard medication

STAT June 13, 2023
The findings are particularly ominous because if adolescents can’t access buprenorphine at residential treatment centers, they’re unlikely to access it elsewhere, said Caroline King, a physician-researcher who conducted the research while studying for her medical degree at Oregon Health and Science University.

Few rehab centers for addicted teens offer recommended medicine, US study finds

The Associated Press June 13, 2023
OHSU research reveals only one in four adolescent residential treatment centers nationwide provide a proven medication to treat opioid use disorder despite an ever-rising number of overdose deaths. Todd Korthuis, M.D., says, “As somebody who’s tried to promote the use of evidence-based treatment for addiction my whole career, it’s just jaw-dropping.”

Gender-Affirming Surgeon Speaks at Jacobs School LGBTQIA+ Event

University at Buffalo June 12, 2023
As an invited speaker at a Jacobs School of Medicine and Biomedical Sciences event, Blair Peters, M.D., describes their work in gender-affirming surgery and how major medical organizations have declared it medically necessary care.

‘More than just the science’: OHSU patient shares story at World Heart Summit

KOIN-TV June 12, 2023
OHSU patient Megan Link recently attended the World Heart Summit, where she shared her experience living with hypertrophic cardiomyopathy as well as her participation in a clinical trial evaluating an experimental drug for the heart condition. Ahmad Masri, M.D., says: “We’re very focused on … implementing the science and trying to get more options to patients.”

Full-On Reversal of Cardiac Amyloidosis Possible With Antibodies

MedPage Today June 12, 2023
In a story exploring rare cases of patients having their cardiac amyloidosis-related heart failure resolving spontaneously after receiving an antibody treatment, Ahmad Masri, M.D., notes two of the three observed cases had a variant form of cardiac amyloidosis, which disproportionately affects people of African descent.

Sun Protection Hacks For Kids Who Hate Sunscreen

Romper June 10, 2023
In an article on “hacks” for getting kids to wear sunscreen, Elizabeth Berry, M.D., says: “If they're going to be out for a really long time, cover them up with whatever you can. Then you're just left to sunscreen whatever skin is showing. It becomes less of a struggle because you're not trying to slop on whole-body sunscreen.”

Can Skin Cancer Be the Same Color as Your Skin?

Verywell Health June 09, 2023
In an article on Amelanotic Melanoma -- a rare type of melanoma that looks colorless or takes on a red, pink, or purple tint -- Elizabeth Berry, M.D., says this form of melanoma is often diagnosed only when it’s more advanced because it’s harder to recognize. She says: “I tell my patients that if a pink bump comes up and does not resolve within four to six weeks like a normal pimple or insect bite should, they should show that bump or spot to a medical provider.”

Risk of falls seen with newer antiandrogens for prostate cancer

MD Edge June 09, 2023
In response to a new study analyzing the risk of falls seen with newer antiandrogens for prostate cancer, Julie Graff, M.D., and Alexandra Sokolova, M.D., publish an editorial suggesting the risk-benefit ratio of adding a second-generation AA to treatment may be different for a patient who wants to stay alert and sharp to keep a complex job "versus someone whose primary goal is to see their young children graduate high school.”
See more stories